Eric Lefkofsky Cares about Chicago

Eric Lefkofsky may be known for his many achievements in the business world, but his philanthropy in the Chicago area and his focus on improving the health and well-being of his local community is what sets him apart. Along with his wife, Liz, and the Lefkofsky Family Foundation, Eric has given grants to the Chicago Museum of Modern Art to allow kids who are 18 years or younger free entrance so they can learn, share and explore the rich Chicago Modern Art movement. Education initiatives include the theater group Steppenwolf for Young Adults. This group annually brings together 15,000 youth from Chicago’s wide array of communities and expands the horizon for many kids who would have been excluded from such experience.

Gifts to the Millenium Park Foundation will continue to allow free access to all the city park has to offer it’s residents and visitors alike. The list is surprisingly vast and varied off all the causes the Foundation supports right here in his local community. Eric’s work as co-founder of Tempus branches out from the many charitable donations to the medical research field made by the Lefkofsky Family Foundation. Tempus is about data-driven information to make research on cancer, treatment of patients and accessibility of such data available to doctors in an easy to understand format.

Using the power of collective knowledge of past and current cancer treatment methods and research, enables doctors and patients to unleash new information and techniques that will revolutionize the way cancer is treated. Helping doctors and patients focus on what is the best course of action in each individual case is what drove Eric and his staff to create this platform, that allows doctors to have the latest data at their fingertips. Data that until now has been spread out across the globe, can now be accessed in real-time so doctors can start an effective treatment plan for their cancer patient. Tempus will dramatically change cancer treatment and the way medical data is handled in the future.